针对代谢性抑郁症的精确治疗方法:综合流行病学,神经科学和精神病学
Kathleen Watson1, Huda Akil2, Natalie Rasgon1
1Center for Neuroscience in Women's Health, Stanford University, Palo Alto, California.
Biological psychiatry global open science
|October 26, 2023
概括
皮奥格利塔可能会改善2型糖尿病和严重抑郁症患者的抗抑郁药反应. 这种胰岛素敏感化药物比DPP4抑制剂和硫氨酸尿素具有优势,这表明它是一种精准医学方法.
科学领域:
- 内分泌学 在内分泌学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 伴随性主要抑郁症 (MDD) 和2型糖尿病 (T2D) 需要量身定制的治疗方法.
- 传统疗法可能对这种患者小组不够.
- 针对胰岛素抵抗的精密药物可以增强抗抑郁药的反应.
研究的目的:
- 评估皮奥格利塔,一种胰岛素敏感剂,在改善抗抑郁药物反应方面的疗效.
- 在患有T2D和MDD的患者中,比较皮奥格利塔与二二酶-4 (DPP4) 抑制剂和硫氨基尿素.
主要方法:
- 在Optum Clinformatics Data Mart数据库上使用了一个模拟的目标试验.
- 评估了4696名T2D患者,将皮奥格利塔与DPP4抑制剂进行比较.
- 进行了对6518名患者的补充分析,将皮奥格利塔与硫尿素进行了比较.
主要成果:
- 仪器变量分析显示,对于抗抑郁药反应,皮奥格利塔比DPP4抑制剂优越.
- 在一年内,Pioglitazone观察到较少的抗抑郁药/抗精神病药物治疗转换/补充.
- 补充分析证实了皮奥格利塔对酸盐的优越性.
结论:
- 皮奥格利塔可能会在患有并发性MDD和T2D的患者中增强抗抑郁药的反应.
- 这些发现支持pioglitazone在这个人群中的使用,与精准医学保持一致.
- 来自观察数据的结果需要谨慎解释.
相关概念视频
Treatment Strategies for Psychological Disorders
145
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
145
Depression: Overview
256
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
256
Antidepressant Drugs: MAOIs and Other Agents
254
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
254
Depressive Disorders: Etiology
104
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
104
Electroconvulsive Therapy
47
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
47
Psychosurgery
58
Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
58


